NRx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET Life Science Investing
Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis Biotech Investing
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis Biotech Investing
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 Life Science Investing
HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results Life Science Investing
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights Life Science Investing
Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences Life Science Investing
Innovotech Inc. Launches of InnovoTEST Hazardous Drug Wipe Testing Kits to Support Pharmacy Compliance and Healthcare Worker Safety Life Science Investing
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
